ZVSA – zyversa therapeutics, inc. (US:NASDAQ)
Stock Stats
News
ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial [Yahoo! Finance]
ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update [Yahoo! Finance]
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
Life Sciences Investor Forum Agenda Announced for November 14th
Form SC 13G/A ZyVersa Therapeutics, Filed by: Anson Funds Management LP
Form 8-K ZyVersa Therapeutics, For: Nov 14
Form 10-Q ZyVersa Therapeutics, For: Sep 30
Form 8-K ZyVersa Therapeutics, For: Nov 05
Form 8-K ZyVersa Therapeutics, For: Oct 29
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.